https://indiaeducationdiary.in/u-s-fda-approves-abrysvo-pfizers-vaccine-for-the-prevention-of-respiratory-syncytial-virus-rsv-in-older-adults/
0
0
6/14/23 at 5:19pm
Organization
India Education Diary
Author
iednewsdesk
60 words
0
Comments
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of lower respiratory tr
You are the first to view
Create an account
or login to join the discussion